Loading chart…
PRE-MARKET
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, North America, and internationally. It operates through Enterprise Medical Solutions, Enterprise Commercial Solutions, and Other segments. The company provides AI-embedded commercialization services for biopharmaceutical, emerging biotech, and medical devices companies.
Indegene Limited (INDGN) is listed on the NSE in the Healthcare sector, Health Information Services industry. The INDGN share price is ₹622.25 (+1.45% today), with a market capitalisation of ₹150B and a price-to-earnings (P/E) ratio of 36.6. MarketRipple tracks the INDGN investment thesis, the ripple-chain impact of market events on Indegene Limited, and the Healthcare sector outlook.
Open
₹615.00
High
₹627.00
Low
₹615.00
Prev. Close
₹613.35
52W High
₹638.00
52W Low
₹414.00
Day range
₹615.00–₹627.00
52-week range
₹414.00–₹638.00
Volume
108K
P/E
36.6
ROE
13.2%
D/E
0.05
Margin
10.0%
Indegene Limited (NSE: INDGN) is currently trading at ₹622.25 (+1.45%).
Indegene Limited's market capitalization is ₹150B.
Indegene Limited's price-to-earnings (P/E) ratio is 36.6.
Indegene Limited operates in the Healthcare sector (Health Information Services).
Analyst consensus on Indegene Limited currently reads strongly positive, based on 8 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.